RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
13.20
-0.55 (-4.00%)
May 13, 2025, 4:00 PM - Market closed
RxSight Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 148.31 | 139.93 | 89.08 | 49.01 | 22.59 | 14.68 | Upgrade
|
| Revenue Growth (YoY) | 46.70% | 57.08% | 81.77% | 116.90% | 53.92% | 554.98% | Upgrade
|
| Cost of Revenue | 41.72 | 40.98 | 35.31 | 27.68 | 18.08 | 12.97 | Upgrade
|
| Gross Profit | 106.59 | 98.94 | 53.77 | 21.33 | 4.52 | 1.71 | Upgrade
|
| Selling, General & Admin | 106.83 | 101.52 | 74.9 | 58.99 | 33.1 | 15.36 | Upgrade
|
| Research & Development | 36.62 | 34.28 | 28.95 | 25.66 | 24.2 | 21.75 | Upgrade
|
| Operating Expenses | 143.45 | 135.8 | 103.85 | 84.65 | 57.3 | 37.11 | Upgrade
|
| Operating Income | -36.86 | -36.86 | -50.09 | -63.32 | -52.79 | -35.41 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -3.31 | -4.95 | -3.68 | -0.51 | Upgrade
|
| Interest & Investment Income | 10.4 | 9.47 | 6.57 | 1.52 | 0.05 | 0.54 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 7.74 | 63.01 | Upgrade
|
| EBT Excluding Unusual Items | -26.49 | -27.41 | -46.82 | -66.75 | -48.68 | 27.64 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.01 | Upgrade
|
| Other Unusual Items | - | - | -1.77 | - | - | - | Upgrade
|
| Pretax Income | -26.49 | -27.41 | -48.59 | -66.75 | -48.68 | 27.63 | Upgrade
|
| Income Tax Expense | 0.06 | 0.05 | 0.02 | 0.01 | 0.01 | 0.06 | Upgrade
|
| Earnings From Continuing Operations | - | -27.46 | -48.61 | -66.76 | -48.69 | 27.58 | Upgrade
|
| Net Income | -26.55 | -27.46 | -48.61 | -66.76 | -48.69 | 27.58 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 24.21 | Upgrade
|
| Net Income to Common | -26.55 | -27.46 | -48.61 | -66.76 | -48.69 | 3.37 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -78.15% | Upgrade
|
| Shares Outstanding (Basic) | 40 | 39 | 34 | 28 | 14 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 39 | 34 | 28 | 14 | 6 | Upgrade
|
| Shares Change (YoY) | 11.26% | 12.81% | 24.56% | 103.02% | 146.28% | -73.12% | Upgrade
|
| EPS (Basic) | -0.67 | -0.71 | -1.41 | -2.41 | -3.57 | 0.91 | Upgrade
|
| EPS (Diluted) | -0.67 | -0.71 | -1.41 | -2.41 | -3.57 | 0.15 | Upgrade
|
| EPS Growth | - | - | - | - | - | -97.42% | Upgrade
|
| Free Cash Flow | -20.52 | -22.39 | -46.41 | -61.24 | -46.65 | -37.74 | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.58 | -1.35 | -2.21 | -3.42 | -6.82 | Upgrade
|
| Gross Margin | 71.87% | 70.71% | 60.36% | 43.52% | 19.99% | 11.62% | Upgrade
|
| Operating Margin | -24.86% | -26.34% | -56.23% | -129.21% | -233.64% | -241.21% | Upgrade
|
| Profit Margin | -17.90% | -19.62% | -54.57% | -136.22% | -215.50% | 22.93% | Upgrade
|
| Free Cash Flow Margin | -13.83% | -16.00% | -52.10% | -124.97% | -206.47% | -257.13% | Upgrade
|
| EBITDA | -33.63 | -33.28 | -46.01 | -59.43 | -48.81 | -31.55 | Upgrade
|
| EBITDA Margin | -22.67% | -23.79% | -51.65% | -121.28% | -216.05% | -214.96% | Upgrade
|
| D&A For EBITDA | 3.24 | 3.58 | 4.08 | 3.88 | 3.98 | 3.85 | Upgrade
|
| EBIT | -36.86 | -36.86 | -50.09 | -63.32 | -52.79 | -35.41 | Upgrade
|
| EBIT Margin | -24.86% | -26.34% | -56.23% | -129.21% | -233.64% | -241.21% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 0.21% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.